Rhumbline Advisers lifted its stake in shares of Anthem Inc (NYSE:ANTM) by 3.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 563,741 shares of the company’s stock after acquiring an additional 21,141 shares during the period. Rhumbline Advisers’ holdings in Anthem were worth $135,354,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of ANTM. Barrow Hanley Mewhinney & Strauss LLC raised its holdings in Anthem by 101.2% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 3,821,672 shares of the company’s stock valued at $1,078,514,000 after buying an additional 1,921,814 shares during the period. Nuveen Asset Management LLC raised its holdings in Anthem by 5,130.7% in the 2nd quarter. Nuveen Asset Management LLC now owns 1,531,222 shares of the company’s stock valued at $432,125,000 after buying an additional 1,501,948 shares during the period. Boston Partners raised its holdings in Anthem by 33.9% in the 2nd quarter. Boston Partners now owns 2,437,084 shares of the company’s stock valued at $688,249,000 after buying an additional 617,137 shares during the period. Prudential PLC raised its holdings in Anthem by 108.1% in the 2nd quarter. Prudential PLC now owns 821,298 shares of the company’s stock valued at $231,673,000 after buying an additional 426,668 shares during the period. Finally, Morgan Stanley raised its holdings in Anthem by 47.2% in the 2nd quarter. Morgan Stanley now owns 1,182,408 shares of the company’s stock valued at $333,685,000 after buying an additional 378,897 shares during the period. Institutional investors and hedge funds own 88.39% of the company’s stock.
In other news, Director Robert L. Dixon, Jr. sold 520 shares of the business’s stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $294.11, for a total transaction of $152,937.20. Following the completion of the transaction, the director now directly owns 9,971 shares of the company’s stock, valued at $2,932,570.81. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.17% of the company’s stock.
Shares of Anthem stock traded down $3.88 on Thursday, reaching $259.63. 102,173 shares of the company were exchanged, compared to its average volume of 1,629,476. Anthem Inc has a 1-year low of $227.16 and a 1-year high of $317.99. The company has a market cap of $66.58 billion, a P/E ratio of 16.31, a price-to-earnings-growth ratio of 0.96 and a beta of 0.73. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.64 and a quick ratio of 1.64. The stock’s 50 day moving average price is $247.38 and its 200-day moving average price is $270.01.
Anthem (NYSE:ANTM) last announced its quarterly earnings data on Wednesday, October 23rd. The company reported $4.87 EPS for the quarter, topping the Zacks’ consensus estimate of $4.82 by $0.05. Anthem had a return on equity of 15.02% and a net margin of 4.21%. The business had revenue of $26.44 billion during the quarter, compared to the consensus estimate of $25.88 billion. During the same period in the previous year, the company posted $3.81 earnings per share. The business’s revenue for the quarter was up 15.1% on a year-over-year basis. On average, research analysts predict that Anthem Inc will post 19.35 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Thursday, December 5th will be given a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a dividend yield of 1.23%. Anthem’s dividend payout ratio is presently 20.14%.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Article: Return on Investment (ROI) Defined, Explained
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.